Evidence map›Paper›PMID 42598859›Full record

ArticleNucleic acids research2026

Seedless 3' pairing enables miR-17 family miRNAs to seize let-7 target sites.

Artur Laski, Anneke Brümmer, Matije Lucic, Elisa Federici, Iris Mestres-Pascual, Jochen Imig, Alexander Kanitz, Mihaela Zavolan, Luca F R Gebert, Ian J MacRae and 2 more

Abstract read
In one paragraph

Article in Nucleic acids research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Artur LaskiInstitute of Pharmaceutical Sciences, Department of Chemistry and Applied Biosciences, ETH Zurich, Zurich, 8093, Switzerland.
Anneke BrümmerBioinformatics Competence Centre, University of Lausanne, Lausanne, 1015, Switzerland.ORCID 0000-0002-3576-0750
Matije LucicInstitute of Pharmaceutical Sciences, Department of Chemistry and Applied Biosciences, ETH Zurich, Zurich, 8093, Switzerland.
Elisa FedericiTumor Biology and Experimental Therapeutics, Institute of Oncology Research, Università della Svizzera Italiana, Bellinzona, 6500, Switzerland.ORCID 0009-0005-8531-1864
Iris Mestres-PascualBiozentrum, University of Basel, Spitalstrasse 41, Basel 4056, Switzerland.ORCID 0009-0001-4428-0695
Jochen ImigMax Planck Institute of Molecular Physiology, Chemical Genomics Centre, Dortmund 44227, Germany.ORCID 0000-0003-0385-1081
Alexander KanitzBiozentrum, University of Basel, Spitalstrasse 41, Basel 4056, Switzerland.
Mihaela ZavolanBiozentrum, University of Basel, Spitalstrasse 41, Basel 4056, Switzerland.ORCID 0000-0002-8832-2041
Luca F R GebertDepartment for Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA 92037, United States.
Ian J MacRaeDepartment for Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA 92037, United States.ORCID 0000-0002-5112-0294
Carlo V CatapanoTumor Biology and Experimental Therapeutics, Institute of Oncology Research, Università della Svizzera Italiana, Bellinzona, 6500, Switzerland.ORCID 0000-0002-7079-557X
Jonathan HallInstitute of Pharmaceutical Sciences, Department of Chemistry and Applied Biosciences, ETH Zurich, Zurich, 8093, Switzerland.ORCID 0000-0003-4160-7135

Funding

Structural and Mechanistic basis for RNA SilencingR35GM127090 · NIGMS · SCRIPPS RESEARCH INSTITUTE, THE · PI IAN JOHN MACRAE · 2018 to 2026
$5.6M
ETH ZurichFoundation Nelia and Amadeo Barletta R35GM127090Krebsliga Schweiz KFS-5504-02-2022-RNIGMS NIH HHS R35 GM127090
6 · The paper itself

Abstract

MicroRNAs (miRNAs) are short noncoding RNAs that post-transcriptionally regulate gene expression. Their canonical function depends on a "seed" sequence at the miRNA 5' end that pairs with conserved sites in the 3' untranslated regions of target messenger RNAs to suppress gene expression. Although seed-mediated targeting is well characterized, the role of the miRNA 3' end remains poorly understood and is challenging to study. Here, we identify a noncanonical mechanism by which miR-106a, a member of the miR-17 family, competes with let-7a for binding to let-7 target sites despite their distinct seed sequences. This binding bypasses miR-106a seed pairing and instead relies on extensive complementarity at its 3' end, which shares sequence identity with the let-7a seed. Such binding of miR-106a does not itself silence these targets but shields them from let-7-mediated suppression, resulting in de-repression of let-7 targets. By contrast, miR-106b, which differs from miR-106a and the other miR-17 family members at its 3' end, lacks this de-repressive activity. These findings show that variation in miRNA 3' sequences can generate divergent functions within a miRNA family and underscore the need to account for 3'-end contributions when interpreting miRNA-target networks and considering the development of miRNA-based therapeutics.

Indexed as

3' Untranslated RegionsMicroRNAsAnimalsBase PairingBase SequenceBinding SitesHumans3' Untranslated RegionsMicroRNAsmirnlet7 microRNA, human

Identifiers

PMID42598859
PMCPMC13473885

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.